UHR-CT vs Conventional CT for Coronary Heart Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether Ultra High-Resolution CT scans (UHR-CT) outperform regular CT scans in detecting blocked heart arteries in individuals with possible coronary heart disease (CHD). The researchers aim to determine if this newer scan technology can provide clearer images without requiring two separate scans. Doctors have advised potential participants to undergo a CT scan due to possible CHD. As an unphased trial, participants can help advance imaging technology that may enhance heart disease diagnosis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that Ultra High-Resolution Computed Tomography (UHR-CT) is safe for coronary heart disease patients?
Research has shown that Ultra High-Resolution CT (UHR-CT) scans are usually well-tolerated and very accurate in diagnosing heart artery disease. However, studies have found that UHR-CT scans expose patients to more radiation than regular CT scans. Despite this, patients handle UHR-CT similarly to regular CT scans.
Regular CT scans are commonly used and have a proven safety record. They are generally well-tolerated and involve less concern about radiation compared to UHR-CT.
Both UHR-CT and regular CT scans are non-invasive tests that help doctors take detailed pictures of the heart and blood vessels. While UHR-CT might provide clearer images, the main safety concern is the higher radiation level, so it's important to weigh the benefits and risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it compares two different types of CT scans to detect coronary heart disease. Unlike the standard CT scans, Ultra High-Resolution CT (UHR-CT) offers much clearer images, which can help doctors spot tiny details that might be missed otherwise. This could lead to more accurate diagnoses and better-informed treatment decisions for patients. Being able to see the heart's structure in such detail is a significant advancement, and it could mean earlier detection and intervention for coronary heart disease.
What evidence suggests that UHR-CT is effective for coronary heart disease?
This trial will compare Ultra High-Resolution CT (UHR-CT) with Conventional CT for detecting coronary heart disease (CHD). Research has shown that UHR-CT holds promise for detecting CHD. Studies indicate that UHR-CT matches the accuracy of invasive coronary angiography, a more traditional and invasive method. UHR-CT also provides clearer images of the coronary arteries, reducing errors in measuring arterial narrowing. One study found that UHR-CT could reclassify over half of patients to a lower risk category by providing more precise images. These findings suggest that UHR-CT could be a valuable tool for identifying heart disease with less invasiveness. Participants in this trial will be assigned to either the UHR-CT arm or the Conventional CT arm to evaluate these potential benefits.1678
Who Is on the Research Team?
Joao Lima, Professor
Principal Investigator
MD
Are You a Good Fit for This Trial?
This trial is for individuals with various forms of heart disease, including coronary artery disease and myocardial ischemia. Participants should be generally at lower risk to assess the effectiveness of a new Ultra High-Resolution CT scan compared to conventional CT scans.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo CT scans using either Conventional Resolution CT or Ultra-High-Resolution CT imaging modalities
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- Conventional Computed Tomography
- Ultra High-Resolution Computed Tomography (UHR-CT)
Conventional Computed Tomography is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, abdominal conditions, and cancer screening
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Canon Medical Systems, USA
Industry Sponsor